// App-Quantinova.ai

: СLINICAL CASE OF THE DEVELOPMENT OF NON-HODGKIN'S LYMPHOMA IN A PATIENT WITH ESSENTIAL THROMBOCYTHEMIA

Researchers

Presenter

  • Maria Mikhaleva

Principal Investigators

  • Sergey Voloshin

  • Alexey Kuvshinov

Medical Centers

  • Clinical Department of Chemotherapy of Hemoblastosis, Depression of Hemopoiesis and Bone Marrow Transplantation,Federal State Budget Institution “Russian Scientific and Research Institute of Hematology and Transfusiology of Federal Medical Biological Agency”,Saint-Petersburg,Russian Federation

  • Clinical Department of Chemotherapy of Hemoblastosis, Depression of Hemopoiesis and Bone Marrow Transplantation,Federal State Budget Institution “Russian Scientific and Research Institute of Hematology and Transfusiology of Federal Medical Biological Agency”,Saint-Petersburg,Russian Federation;Military Medical Academy named after S.M. Kirov,Saint-Petersburg,Russian Federation;North-Western State M

Locations

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Angiology

  • Oncology (ONC)

Disease

  • Superficial Vein Thrombosis

  • Essential thrombocythemia

  • Alpha-thalassemia myelodysplasia syndrome

  • Chronic Myelogenous Leukemia

  • Non-Hodgkin's Lymphoma

  • Hodgkin's Lymphoma

  • Polycythemia vera

  • Myeloid neoplasms

  • Myelofibrosis

  • Non‐Hodgkin Lymphoma

  • Venous thrombosis

  • Lymphomas

Biomarkers

  • Anaplastic lymphoma Kinase

  • B-lymphocyte antigen CD20

  • Cluster of Differentiation 4

  • Cluster of differentiation 45

  • Cluster of Differentiation 5

  • Interferon

Drug/Treatment

  • Adcetris

  • Bendamustine

  • Clopidogrel bisulfate

  • Interferon

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved